| Literature DB >> 7474765 |
A Dimitrova, G Tsarianski, V Aleksandrov, P Kereshka, G Nachev, A Chirkov.
Abstract
We describe a case of a patient with moderate hemophilia B, undergoing CABG. Substitution therapy was realized with factor IX concentrate (Bebulin-TIM4-IMMUNO). We discuss which of the following factors: hypothermia, hemodilution of heparinisation has a substantial role in alteration of FIX coagulant activity during cardiopulmonary bypass.Entities:
Mesh：
Substances：
Year: 1995 PMID： 7474765
Source DB: PubMed Journal: Khirurgiia (Sofiia) ISSN： 0450-2167